← All Sponsors
SPONSOR

Allogene Therapeutics

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Systemic Lupus Erythematosus (With and Without Nephritis)Idiopathic Inflammatory MyopathySystemic Sclerosis
NCT07085104 Phase 1
Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Systemic Lupus Erythematosus (With and Without Nephritis)
United States, Canada View Trial →